What is the treatment for Klebsiella variicola (K. variicola) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Research

Klebsiella variicola urinary tract infections (UTIs) should be treated with antibiotics such as nitrofurantoin, fosfomycin, or pivmecillinam as first-line options, considering the high rates of resistance to trimethoprim-sulfamethoxazole and ciprofloxacin, as well as the potential for extended-spectrum beta-lactamases (ESBLs) production. The treatment of Klebsiella variicola UTIs requires careful consideration of the antibiotic resistance patterns of the bacteria. According to a study published in 2020 1, the recommended first-line empiric antibiotic therapy for acute uncomplicated bacterial cystitis includes a 5-day course of nitrofurantoin, a 3-g single dose of fosfomycin tromethamine, or a 5-day course of pivmecillinam.

  • Key considerations in treating K. variicola UTIs include:

    • High rates of resistance to trimethoprim-sulfamethoxazole and ciprofloxacin, which preclude their use as empiric treatment in several communities 1
    • Potential for ESBLs production, which may limit treatment options and require the use of carbapenem antibiotics like meropenem 1
    • Importance of accurate identification and susceptibility testing to guide effective treatment, as K. variicola was previously misidentified as K. pneumoniae but is now recognized as a distinct species with potentially different antibiotic resistance patterns 2, 3
  • Treatment options for K. variicola UTIs may include:

    • Oral antibiotics such as nitrofurantoin, fosfomycin, or pivmecillinam as first-line options 1
    • Parenteral treatment options such as piperacillin-tazobactam, carbapenems, or ceftazidime-avibactam for more severe infections or resistant strains 1
    • Alternative options such as amikacin, gentamicin, fosfomycin, or polymyxin B for strains with specific resistance patterns 4

It is essential to prioritize the use of the most recent and highest-quality studies to guide treatment decisions, such as the 2020 study published in Postgraduate Medicine 1, which provides recommendations for the treatment of UTIs caused by antibiotic-resistant Gram-negative bacteria, including K. variicola. Additionally, a 2023 study published in Infection and Drug Resistance 4 highlights the emergence of OXA-484-producing K. variicola in China, emphasizing the need for continued surveillance and adaptation of treatment strategies to address the evolving landscape of antibiotic resistance.

Related Questions

What is the recommended treatment for a symptomatic adult with a urine culture growing Escherichia coli at 10,000‑49,000 CFU/mL?
In a 19-year-old woman with recurrent urinary tract infections and vaginal colonization with Klebsiella pneumoniae, Escherichia coli, and Enterococcus faecalis, what is the appropriate next management?
What is the appropriate antibiotic treatment for a 22-year-old woman with urinary tract infection symptoms, a urine culture growing Group B Streptococcus (10,000 CFU/mL) sensitive to penicillins, who cannot tolerate nitrofurantoin due to gastrointestinal side effects and now has worsening back pain suggestive of ascending infection?
In a 23-year-old patient with a urine culture positive for Escherichia coli, what is the appropriate antibiotic treatment?
In a 62-year-old woman with recurrent Escherichia coli urinary tract infections whose urine culture shows resistance to gentamicin and trimethoprim‑sulfamethoxazole and intermediate susceptibility to ciprofloxacin and ampicillin, which low‑dose antibiotic can be used for prophylaxis?
What is one unit of red blood cells (RBCs) and what dose is indicated in adults and pediatrics?
What is the treatment for a fractured metacarpal (metacarpal bone)?
What are the treatment options for late-stage dementia?
What is the risk of toxicity from ingesting one over-the-counter (OTC) boric acid supplement orally?
How often should an adult have lipid profile (lipid panels) tests done?
At what age is strabismus (strabismus, a disorder of ocular alignment) surgery typically performed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.